Emalex Biosciences
Paul Reinfelds serves as Senior Vice President of Legal Affairs and General Counsel at Emalex Biosciences. He oversees all aspects of corporate and legal matters at Emalex.
Dr. Reinfelds has spent the last 15 years in the pharmaceutical space previously serving as General Counsel at MMB Healthcare and its affiliated companies, Associate General Counsel at Marathon Pharmaceuticals, LLC, Senior Director of U.S. Legal Affairs at Lundbeck Inc., and as Legal Counsel at Ovation Pharmaceuticals. Prior to his legal career, he was a research scientist.
Dr. Reinfelds earned his Ph.D. in Biology from Illinois Institute of Technology, a Juris Doctor from the University of Illinois Chicago School of Law and is a registered patent attorney with the United States Patent and Trademark Office.
This person is not in any teams
Emalex Biosciences
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.